T = 0 | Injection FDG |  |
T = 5 | Start MRI | Axial T2-weighted imaging |
 |  | T1 in- and opposed phase GRE |
 |  | Diffusion-weighted imaging |
 |  | Fat-suppressed T1-weighted eThrive (contrast enhanced) |
- pre-contrast | ||
- arterial phase (bolus tracking) | ||
- portovenous phase (70Â sec delay) | ||
- late venous phase (200Â sec delay) | ||
 |  | Attenuation sequence (skullbase – midthigh) |
 |  | Whole body T1-weighted mDixon (skullbase – midthigh) |
T = 60 |  | PET skullbase – midthigh |
T = 75 | End PET-MRI | Transfer to PET-CT |
T = 95 | Start PET-CT | PET skullbase – midthigh |
low dose CT | ||
4-phase CT liver | ||
- pre-contrast | ||
- arterial phase (bolus tracking) | ||
- portovenous phase (70Â sec delay) | ||
- late venous phase (240Â sec delay) | ||
T = 145 | End PET-CT |  |